{"id":"W4283698327","doi":"10.1136/annrheumdis-2022-eular.2168","title":"POS1422 USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND RISK OF MULTIPLE MYELOMA IN PERSONS WITH RHEUMATOID ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Abatacept; Leflunomide; Tocilizumab; Rheumatoid arthritis; Hydroxychloroquine; Internal medicine; Rituximab; Sulfasalazine; Incidence (geometry); Etanercept; Infliximab; Medical prescription; Tofacitinib; Antirheumatic drugs; Antirheumatic Agents; Disease; Lymphoma; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004605896,0.0002006462,0.0006837299,0.0001579319,0.0001927832,0.00001100552,0.0003094054,0.00005105064,0.0002023356],"category_scores_gemma":[0.0009912408,0.0001358862,0.0002281521,0.0003299734,0.0007135808,0.0001153095,0.0003168728,0.0002032241,7.959793e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009603035,"about_ca_system_score_gemma":0.00009847397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006328556,"about_ca_topic_score_gemma":0.00003030465,"domain_scores_codex":[0.9978105,0.0008659877,0.0006377845,0.0002503903,0.0001516385,0.0002836722],"domain_scores_gemma":[0.9976248,0.001156695,0.0005872524,0.0004871222,0.00007777536,0.000066352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002044957,0.002258409,0.919043,0.001303513,0.00163464,0.000005891842,0.003445761,0.0009494941,0.002008508,0.0008541006,0.001376205,0.06507549],"study_design_scores_gemma":[0.003105459,0.0004714351,0.9796846,0.002689315,0.0003032116,0.00001727267,0.003944726,0.001750134,0.005810727,0.001605498,0.0002221493,0.0003954773],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862201,0.01151299,0.00004448919,0.0004643066,0.00007531094,0.0003681084,0.001288033,0.00001302497,0.00001358408],"genre_scores_gemma":[0.994114,0.005392347,0.000299253,0.0000716103,0.000001136501,0.00003256212,0.0000160629,0.0000168746,0.0000561003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06468002,"threshold_uncertainty_score":0.5541277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03406212049642918,"score_gpt":0.2689386530115542,"score_spread":0.234876532515125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}